[Federal Register Volume 70, Number 30 (Tuesday, February 15, 2005)]
[Notices]
[Page 7760]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-2880]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 16, 2004, Clariant LSM 
(Missouri) Inc., 2460 W. Bennett Street, (or P.O. Box 1246, zip: 
65801), Springfield, Missouri 65807-1229, made application to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of Methylphenidate (1724), a basic class of controlled 
substance listed in Schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for research purposes.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register. 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than April 18, 2005.

    Dated: February 9, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-2880 Filed 2-14-05; 8:45 am]
BILLING CODE 4410-09-P